Die Vision des Unternehmens ist großartig! Die Mitarbeiter sind fantastisch und sehr engagiert. Unsere Führungskräfte sind freundlich, hilfsbereit und erfahren! Es ist, wie mit der Familie zu arbeiten.
Ausgezeichnetes Führungsteam, sehr kreativ und fortschrittlich. Großartiges Arbeitsklima und gute Betreuung der Mitarbeiter. Eine tolle Gelegenheit, mit Wissenschaftlern und Ärzten zusammenzuarbeiten und einen positiven Beitrag zum Team und Unternehmen zu leisten.
Großartiges Unternehmen mit großartiger Zielsetzung. Ausgezeichnete Arbeitsethik und Transparenz des Managements.
I’ll never forget the day I first heard about Prolacta.
It was 2013, and I was waiting to board a flight when a recruiter called to tell me about Prolacta’s opening for a director of quality. Normally, I wouldn’t have answered the phone, but as luck would have it my flight was delayed, so I decided to pick up. I remember being immediately intrigued by the concept of 100% human milk–based nutritional products for premature infants and decided to interview for the position.
At that point in time, I had nearly 30 years of experience managing quality for the plasma industry under my belt, including serving as head of quality (southwest division) for Grifols, the world’s largest producer of blood plasma–based products, and serving as the plasma center manager for Bayer Corporation, one of the world’s largest pharmaceutical companies.
I was excited for the opportunity to put my extensive plasma industry skills and insights into practice at Prolacta, and that enthusiasm has not waned. For the last eight years, I have had the privilege of overseeing Prolacta’s quality assurance (QA) and in 2018, quality control (QC).
At Prolacta, we adhere to the highest quality and safety standards. In fact, we were the first company to adopt the safety measure of DNA matching to ensure all milk received comes directly from our carefully screened and vetted donors.
In my role as senior director of quality, I am responsible for ensuring that all of Prolacta’s systems, procedures, and practices are intact and comply with the policies and requirements of all major regulatory agencies.
While I truly enjoy all aspects of my job, I am by far the proudest of my role as chair of the recently established Athari Council at Prolacta. Created in 2020, the Athari Council is dedicated to the study and advancement of Black maternal health and equity in neonatal intensive care units (NICUs).
The goal of the Athari Council is to uplift Black families in the NICU and beyond by working closely with select, like-minded organizations throughout the US to educate and enlighten healthcare providers to improve care for these families. Comprised of eight employee members (and counting!), the Athari Council is focused on making a tangible contribution to the fight against healthcare inequities, especially among Black families and how they are treated in the NICU.
Raising awareness of racial disparities in the NICU isn’t the only way Prolacta strives to create a diverse and inclusive workplace. The company also offers the Women’s Leadership Development Academy (WLDA). Created in 2018, WLDA provides access to education, mentorship, and networking opportunities to help support the professional advancement of women.
I am thankful for the collaborative culture that Prolacta instills in all of its employees. I also value the support I have received from my colleagues over the last eight years, in particular with my new role as chair of the Athari Council.
As we look forward, I am excited about the opportunity to help close the gap on health inequality facing Black families in NICUs and beyond while also continuing to help save the lives of thousands of premature infants worldwide via our high-quality, lifesaving nutritional products.
I’ve been with Prolacta since Day One. It was nearly 20 years ago that I became the company’s first official employee, and I’ve never looked back. Joining Prolacta is the best career decision I ever made.
At Prolacta, I’ve helped make history by pioneering 100% human milk–based nutritional products for premature infants. Together, we have benefited more than 90,000 fragile babies throughout the world and counting.
In those early days, I had the rare opportunity to be a part of something that had never been done before – to build a brand-new industry from the ground up in the field of human milk science.
It started with an idea that feeding fragile premature infants a diet derived exclusively from human milk could help address the many complications and feeding intolerance issues associated with cow milk-based nutrition. We worked with scientists from around the world to create the first and only human milk–based neonatal nutritional fortifier made from 100% donor breastmilk – and conducted our first clinical trial in 2007. This proved to be the turning point for our company.
Results from that study not only demonstrated improvements in the devasting complications that affect premature infants, such as necrotizing enterocolitis, but also reduced hospital costs. It’s an honor to have been a part of this landmark study, and to continue to help in the innovation process that results in products that help save neonatal patients from the devastation of prematurity.
In my role as vice president, clinical research and development, I am able to continuously sharpen my clinical research skills by organizing studies on our products that have never been done before, and producing data that supports new ideas. In fact, I am currently working on new clinical studies in infants who are born with cardiac and gastrointestinal defects to demonstrate how Prolacta’s Exclusive Human Milk Diet can help them. We do this not because these are huge populations – in fact, fewer than five out of 100,000 infants are born with single ventricle pathology – but because we know that a specialized human milk fortifier could help support their growth and recovery.
As the first employee, it’s been awe-inspiring to see the company grow from a team of two – myself and the founder – to a thriving team of more than 300 employees from around the world. Everyone at Prolacta is passionate about what they do and I love working with each and every team member. There’s a strong sense of comradery that reverberates throughout the company. All of us truly believe that we’re working to make a difference in the world and save lives.
I’ve authored or co-authored more than 240 scientific studies. Prior to Prolacta, I spent more than 20 years working at some of the world’s top healthcare companies. I’ve also been an adjunct professor at the University of California, Los Angeles since 1979, and a professor at Charles R. Drew University since 2000.
However, none of these career experiences compare to the meaningful impact I’ve made on the neonatal population in my role at Prolacta, and I am reminded of the value of our work every year. During the holidays, each employee receives an ornament with a number on it. That number represents the number of babies’ lives saved that year from our team efforts. In 2019, that number was 774.
For me, this represents the culmination of the work I embarked on almost 20 years ago at Prolacta. We’ve done great things and will continue to do so as we show the difference that human milk nutrition can bring to vulnerable populations worldwide.
For the last 12 years, I’ve seen and studied the benefits of an Exclusive Human Milk Diet (EHMD) in the neonatal intensive care unit (NICU). I first learned about an EHMD for neonatal patients back in 2008 while working as a neonatal dietitian at Randall Children’s Hospital in Portland, Oregon.
The improved outcomes of patients fed an EHMD at Randall Children’s were so impressive that I wanted to help co-author and share with others our best practices that were helping babies. This research includes multiple clinical papers including a 2014 study that showed a statistically significant decrease in necrotizing enterocolitis rate by using an EHMD and a 2018 study on the impacts of an EHMD on premature infant growth.
It was this passion for neonatal health and nutrition that led me to Prolacta in 2018. One of my roles is serving as the company’s Director, Medical Science Liaisons and Clinical Nutrition to manage the Nutrition Advisory Committee (NAC). NAC offers clinicians direct access to third-party dietitians to answer questions about neonatal nutrition and optimal use of our products. This is important because it offers objective information that further underscores the value of our work. To me, the NAC is one of the things that truly sets Prolacta apart from other companies in the industry.
I love putting the insight and knowledge I gained during my almost 20-year tenure at Randall Children’s into practice at Prolacta. It is extremely rewarding to help hospitals generate the best outcomes for very low birth weight infants.
While I miss working with babies in the NICU, my role at Prolacta helps me make an impact on an even greater number of babies by providing real-world EHMD experience. It means a lot to me knowing that my job has helped to change the lives of over 63,000 fragile premature infants throughout the world and counting!
At Prolacta, I also enjoy being surrounded by compassionate people who share my commitment to neonatal nutrition and babies. We have an impressive team of experts who are all working towards the common goal of helping at-risk babies thrive, and I am truly honored to play a small part in helping to achieve this mission. Nothing feels better than knowing that what you do every day is helping to make a meaningful difference in the world!
Although I’ve been with Prolacta for 15 years, I can still remember the excitement I felt after walking out of my first interview like it was yesterday.
It was 2005, and I had been working as a manufacturing supervisor at a therapeutics company for 12 years when I was approached about joining Prolacta.
I was completely fascinated with the idea of creating 100% human milk–based nutritional products, and inspired by the potential to impact the lives of thousands of fragile babies worldwide. It was a mission that I just knew I had to be a part of, so I immediately accepted the position of manufacturing manager.
During my first year on the job, I was charged with finding an instrument that could analyze human breastmilk for things like fat, protein, and calories, and then pasteurize and fortify the milk to create our life-saving products. I knew it wasn’t going to be an easy feat. However, if there’s one thing I love about working at Prolacta it’s that we persevere as a team. Throwing in the towel and giving up is simply not in our company culture’s DNA. What is in our DNA is innovative, outside-the-box thinking.
So, I researched everything from food and dairy equipment to pharmaceutical and finally identified what we needed to bring our breastmilk analysis to life.
Today, my team and I work to ensure that we always have product available to serve the nutritional needs of premature infants, and I am proud to say that we continuously achieve that. More than 63,000 premature infants worldwide have experienced proven clinical benefits from our 100% human milk–based nutritional products. This is because everyone here at Prolacta is passionately committed to what they do.
I love the people I work with and often spend time with them outside of work. I organize a yearly barbeque for all of us to get together. We setup in the parking lot and I cook up the meat and everyone brings different sides and drinks. It’s a fun occasion that we all look forward to.
Prolacta has provided me with wonderful opportunities over the years. I am grateful to have played a role in our initial clinical trial and other key studies. It’s amazing to think of all that we have accomplished.
In fact, I am reminded every day of just how far we’ve come. In our conference room sits our original pasteurization tank enclosed in a glass case. That tank had the capacity to concentrate 80 liters of donor milk into five liters of our fortifier. Today, we just processed 3500 liters of donor milk into 475 liters of our fortifier. This was our largest batch to date and will help hundreds of infants throughout the world.
Wir bei Prolacta arbeiten mit großer Hingabe daran, die Gesundheit von Patienten zu verbessern. Viele unserer Beschäftigten haben ihre Karriere der Neonatalpflege gewidmet und bereits mehr als 90.000 frühgeborene Kinder haben von unseren Produkten profitiert.1 Gemeinsam sind wir erfolgreich, denn wir wissen, dass unsere Arbeit einen echten Unterschied macht – nicht nur für die schutzbedürftigen Patienten, die wir versorgen, sondern auch für deren Familien.
Prolacta setzt sich für seine Mitarbeiter ein und bietet ihnen daher hervorragende Vergütungen und Sozialleistungen, wie z. B.:
Wir suchen immer nach Wegen, gemeinsam zu feiern. Wir haben eine Vielzahl von persönlichen und virtuellen Veranstaltungen für unsere Beschäftigten und deren Familien, an denen sie teilnehmen können, darunter Townhall-Meetings, Kunst- und Handwerks-Events, Happy Hours und Märchenstunden für Kinder mit unserem CEO.